EUVIMEDEUVIMED entdecken
Crossref

The indication and treatment outcome predictors of mifepristone treating ectopic pregnancy

Panpan Tang, Huixia Ye, Yingxiang Wang, Wenwei Li, Chenyi Liao, Xiaomao Li, Yuebo Yang

Archives of Gynecology and Obstetrics · 2023

DOI: 10.1007/s00404-023-06998-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, 2023. Verfasst von Panpan Tang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gynecology Department, The Third Affiliated Hospital of Sun Yat-Sen University, 600# Tianhe Road, Guangzhou, People's Republic of China. Hauptthemen laut MEDLINE: Mifepristone, Pregnancy, Ectopic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: Ectopic pregnancy is a life-threatening disease and is an important cause of pregnancy-related mortality. MTX is the primary conservative treatment medicine of ectopic pregnancy, and mifepristone is also a promising medicine. Through studying the ectopic cases at the third affiliated hospital of Sun Yat-Sen University, the study aims to analyze the indication and treatment outcome predictors of mifepristone. METHODS: The data of 269 ectopic pregnancy cases treated with mifepristone during the year 2011-2019 were retrospectively collected. Logistic-regression analysis was used to analyze the factors affiliated with the treatment outcome of mifepristone. Then ROC curve was used to analyze the indication and predictors. RESULTS: Through logistic-regression analysis, HCG is the only factor related to the treatment outcome of mifepristone. The AUC of ROC curve predicting treatment outcome with pre-treatment HCG is 0.715, and the cutoff value of ROC curve is 372.66 (sensitivity 0.752, specificity 0.619). The AUC of 0/4 ratio predicting the treatment outcome is 0.886, and the cutoff value is 0.3283 (sensitivity 0.967, specificity 0.683). The AUC of 0/7 ratio is 0.947, and the cutoff value is 0.3609 (sensitivity 1, specificity 0.828). CONCLUSIONS: Mifepristone can be used to treat ectopic pregnancy. HCG is the only factor related to the treatment outcome of mifepristone. Patients with HCG less than 372.66 U/L can be treated by mifepristone. If HCG descends more than 67.18% on the 4th day or 63.91% on the 7th day, it is more likely to have a successful treatment outcome. It is more precise to retest on the 7th day.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MifepristonePregnancy, EctopicPregnancyFemaleHumansRetrospective StudiesMethotrexateTreatment OutcomeChorionic Gonadotropin, beta Subunit, Human

Stichwörter der Autor:innen

Ectopic pregnancyHCGMifepristone

Substanzen

MifepristoneMethotrexateChorionic Gonadotropin, beta Subunit, Human

Autor:innen und Institutionen

  • Gynecology Department, The Third Affiliated Hospital of Sun Yat-Sen University, 600# Tianhe Road, Guangzhou, People's Republic of China.
  • Gynecology Department, The Third Affiliated Hospital of Sun Yat-Sen University, 600# Tianhe Road, Guangzhou, People's Republic of China. lixmao@mail.sysu.edu.cn.
  • Gynecology Department, The Third Affiliated Hospital of Sun Yat-Sen University, 600# Tianhe Road, Guangzhou, People's Republic of China. yangyueb@mail.sysu.edu.cn.

Zitieren

APA

Tang, P., Ye, H., Wang, Y., Li, W., Liao, C., Li, X., & Yang, Y. (2023). The indication and treatment outcome predictors of mifepristone treating ectopic pregnancy. Archives of Gynecology and Obstetrics. https://doi.org/10.1007/s00404-023-06998-7

Vancouver

Tang P, Ye H, Wang Y, Li W, Liao C, Li X, et al. The indication and treatment outcome predictors of mifepristone treating ectopic pregnancy. Archives of Gynecology and Obstetrics. 2023. doi:10.1007/s00404-023-06998-7

BibTeX
@article{Tang2023,
  author = {Tang, Panpan and Ye, Huixia and Wang, Yingxiang and Li, Wenwei and Liao, Chenyi and Li, Xiaomao and Yang, Yuebo},
  title = {The indication and treatment outcome predictors of mifepristone treating ectopic pregnancy},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2023},
  doi = {10.1007/s00404-023-06998-7}
}
Kostenlos starten →